Trial Details
COMPLETEDBasic Information
| Clinical ID | c3359 |
|---|---|
| Identifier | NCT02177071 |
| Trial Title | A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: INFLIXIMAB|DRUG: AZATHIOPRINE|DRUG: MERCAPTOPURINE|DRUG: Methotrexate |
Participant Information
| Sponsor | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives |
|---|---|
| City | Melbourne |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2015-10-09 |
|---|---|
| Primary Completion Date | 2021-06 |
| Completion Date | 2021-10 |